Salta al contenuto principale
Passa alla visualizzazione normale.

LUISA TESORIERE

Suicidal erythrocyte death in metabolic syndrome

  • Autori: Restivo I.; Attanzio A.; Tesoriere L.; Allegra M.
  • Anno di pubblicazione: 2021
  • Tipologia: Articolo in rivista
  • Parole Chiave: Atherosclerosis; Diabetes; Dyslipidemia; Endothelial dysfunction; Eryptosis; Hypertension; Metabolic syndrome; Obesity; Oxidative stress; Vascular damage
  • OA Link: http://hdl.handle.net/10447/488227

Abstract

Eryptosis is a coordinated, programmed cell death culminating with the disposal of cells without disruption of the cell membrane and the release of endocellular oxidative and pro-inflammatory milieu. While providing a convenient form of death for erythrocytes, dysregulated eryptosis may result in a series of detrimental and harmful pathological consequences highly related to the endothelial dysfunction (ED). Metabolic syndrome (MetS) is described as a cluster of cardiometabolic factors (hyperglycemia, dyslipidemia, hypertension and obesity) that increases the risk of cardiovascular complications such as those related to diabetes and atherosclerosis. In the light of the crucial role exerted by the eryptotic process in the ED, the focus of the present review is to report and discuss the involvement of eryptosis within MetS, where vascular complications are utterly relevant. Current knowledge on the mechanisms leading to eryptosis in MetS-related conditions (hyperglycemia, dyslipidemia, hypertension and obesity) will be analyzed. Moreover, clinical evidence supporting or proposing a role for eryptosis in the ED, associated to MetS cardiovascular complications, will be discussed.